Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults [NA]
Overview of the my.naviGATE guide for after-treatment effects in adolescents and young adults with sarcoma and related cancers; the study is…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia. [Phase 3]
A Phase 3 randomized pragmatic trial named IMPACT-AML is investigating relapsed or refractory acute myeloid leukemia and is currently recrui…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation [Phase 1]
This is a Phase 1 trial update announcing ongoing recruitment for a study evaluating TSC-100 and TSC-101 in patients with acute myeloid leuk…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study [Phase 1, Phase 2]
PedAL BCU, LLC is conducting a pediatric screening trial to test bone marrow and blood methods in children with relapsed or hard-to-treat ac…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Backtracking Leukemia-Typical Somatic Mutations in Cord Blood
A clinical trial is actively recruiting to study leukemia-associated somatic mutations in cord blood for acute lymphoblastic leukemia and ac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents [Phase 2]
Phase 2 clinical trial update evaluating the triple combination of Tagraxofusp, Azacitidine, and Venetoclax in newly diagnosed secondary acu…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia [Phase 2]
This is a Phase 2 clinical trial evaluating venetoclax plus azacitidine in combination with chidamide and the CAG regimen for fit, older pat…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm Trial [Phase 2]
A Phase 2 multicenter prospective single-arm trial evaluating the VA-CIG regimen as first-line treatment for previously untreated acute myel…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A clinical trial is enrolling people with and without cancer to collect blood samples and evaluate tests for early cancer detection across m…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML) [Phase 3]
This Phase 3 clinical trial assesses bleximenib in combination with standard induction/consolidation therapy followed by maintenance for adu…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating venetoclax in combination with a CACAG regimen versus the 3+7 regimen for acute monocytic leukemia is cu…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing Treatment
An exploratory UK clinical trial sponsored by the University of Oxford is evaluating wearable technology to collect health data in people wi…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy [NA]
This ClinicalTrials.gov entry describes a collaborative palliative and leukemia care model for patients with AML or myelodysplastic syndrome…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies [Phase 2]
Phase 2 clinical trial evaluating MT2021-08T, a T-cell receptor alpha/beta-depleted donor peripheral blood stem cell product, for hematologi…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Leukemia Adapted Protocol
This is an update on an ongoing clinical trial (NCT06928909) at Baylor College of Medicine evaluating an adapted protocol for acute myeloid …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) [Phase 2, Phase 3]
The AZTOUND study is evaluating ASTX030 (azacitidine and cedazuridine) alone or in combination with venetoclax in myeloid neoplasms includin…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation [Phase 1]
Phase 1 trial evaluating CIML NK cell infusion for relapse of myeloid disease after hematopoietic cell transplantation; the study is current…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML [Phase 1]
A Phase 1 clinical trial is testing an adoptive T cell therapy combined with a DC/AML fusion vaccine plus decitabine and venetoclax in acute…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Telehealth Advance Care Planning Intervention [NA]
An ongoing clinical trial at the University of Rochester is evaluating a telehealth advance care planning intervention for myeloid malignanc…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML [Phase 1, Phase 2]
Phase 1b/2 clinical trial evaluating azacitidine (AZA) in combination with APG1252 for high-risk acute myeloid leukemia; the study is not ye…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG) [Phase 2]
An exploratory Phase 2 study evaluating VHAG (venetoclax, homoharringtonine, azacitidine, plus G-CSF) for newly diagnosed acute myeloid leuk…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood [Phase 1, Phase 2]
This ClinicalTrials.gov update describes a Phase 1/Phase 2 trial evaluating the safety and efficacy of quizartinib in children and young adu…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy
A clinical trial update notes an ongoing study evaluating the immune profile of acute myeloid leukemia patients receiving azacitidine plus v…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: BCL2i CLAG-M in R/R Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial is evaluating a BCL-2 inhibitor in combination with the CLAG-M regimen for relapsed or refractory acute myeloid leukemia and…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML [Phase 3]
A Phase 3 clinical trial compares quizartinib plus chemotherapy to placebo plus chemotherapy in newly diagnosed FLT3-ITD negative acute myel…